The RMR Group Announces Vertex Pharmaceuticals’ 15-Year Lease Renewal for 1.1 Million Square Feet in Boston’s Seaport District

Business Wire08-19

NEWTON, Mass., August 19, 2024--(BUSINESS WIRE)--The RMR Group (Nasdaq: RMR) today announced the early renewal of the Vertex Pharmaceuticals Incorporated ("Vertex") lease for 1.1 million square feet ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2460338310?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/TH29mndsVPfIkNkuixKBDg--~B/aD00MjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/2c7bac5806de8607047310ee5d16a5c8","is_english":true,"pubTime":"2024-08-19 20:00","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2460338310","market":"us","top_or_hot":-1,"title":"The RMR Group Announces Vertex Pharmaceuticals’ 15-Year Lease Renewal for 1.1 Million Square Feet in Boston’s Seaport District","media":"Business Wire","content":"<div>\n<p>NEWTON, Mass., August 19, 2024--(BUSINESS WIRE)--The RMR Group (Nasdaq: RMR) today announced the early renewal of the Vertex Pharmaceuticals Incorporated (\"Vertex\") lease for 1.1 million square feet ...</p>\n\n<a href=\"https://finance.yahoo.com/news/rmr-group-announces-vertex-pharmaceuticals-120000110.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The RMR Group Announces Vertex Pharmaceuticals’ 15-Year Lease Renewal for 1.1 Million Square Feet in Boston’s Seaport District</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe RMR Group Announces Vertex Pharmaceuticals’ 15-Year Lease Renewal for 1.1 Million Square Feet in Boston’s Seaport District\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-19 20:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/rmr-group-announces-vertex-pharmaceuticals-120000110.html><strong>Business Wire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEWTON, Mass., August 19, 2024--(BUSINESS WIRE)--The RMR Group (Nasdaq: RMR) today announced the early renewal of the Vertex Pharmaceuticals Incorporated (\"Vertex\") lease for 1.1 million square feet ...</p>\n\n<a href=\"https://finance.yahoo.com/news/rmr-group-announces-vertex-pharmaceuticals-120000110.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2362540622.SGD","symbol_name":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","start_time":0,"source_url":"https://finance.yahoo.com/news/rmr-group-announces-vertex-pharmaceuticals-120000110.html","article_id":"2460338310","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/TH29mndsVPfIkNkuixKBDg--~B/aD00MjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/2c7bac5806de8607047310ee5d16a5c8"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2460338310","pubTimestamp":1724068800,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"NEWTON, Mass., August 19, 2024----The RMR Group  today announced the early renewal of the Vertex Pharmaceuticals Incorporated  lease for 1.1 million square feet of office and laboratory space at 50 Northern Avenue and 11 Fan Pier Boulevard in Boston, Massachusetts. Vertex’s existing lease, which expires in December 2028, was extended for approximately 15 years, through June 2044.Adam Portnoy, President and Chief Executive Officer of RMR, made the following statement:. \"The Vertex lease extension exemplifies the successful execution of The RMR Group’s strategy to create value for our clients. We have cultivated a strong relationship with Vertex, which has resulted in their recommitting to their flagship location in Boston’s Seaport District for a 15-year lease extension that enhances the value of our clients’ assets. We look forward to continuing our longstanding relationship with Vertex and providing them with a supportive environment for Vertex to pursue transformative medicines for p","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","LU1069344957.HKD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (HKD) INC","LU0058720904.USD":"联博国际健康护理基金A","BK4532":"文艺复兴科技持仓","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","IE00B19Z9P08.USD":"LEGG MASON CLEARBRIDGE US AGGRESSIVE GROWTH \"A\" (USD) INC","VERX":"Vertex, Inc.","IE00B19Z9Z06.USD":"Legg Mason ClearBridge - US Aggressive Growth A Acc USD","BK4567":"ESG概念","BK4193":"多样化房地产活动","BK4139":"生物科技","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU2236285917.USD":"ALLIANZ GLOBAL INCOME \"AMG\" (USD) INC","BK4533":"AQR资本管理(全球第二大对冲基金)","RMR":"The RMR Group Inc","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU2417539215.USD":"ALLIANZ GLOBAL INCOME \"AMF\" (USD) INC","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU2456880835.USD":"ALLIANZ GLOBAL INCOME \"AT\" (USD) ACC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","BK4588":"碎股","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","LU2462157665.USD":"ALLIANZ GLOBAL INCOME \"A\" (USD) INC","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","LU1035775433.USD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (USD) INC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","IE00BZ9MQY76.HKD":"FTGF CLEARBRIDGE US AGGRESSIVE GROWTH \"A\" (HKD) ACC","VRTX":"福泰制药","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","IE00B894F039.SGD":"Legg Mason ClearBridge - US Aggressive Growth A Acc SGD-H","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU0079474960.USD":"联博美国增长基金A","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","BK4023":"应用软件"},"translate_title":"RMR集团宣布与Vertex Pharmaceuticals续签波士顿海港区110万平方英尺的15年租约","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VRTX":1,"VERX":1,"RMR":1},"content_text":"NEWTON, Mass., August 19, 2024--(BUSINESS WIRE)--The RMR Group (Nasdaq: RMR) today announced the early renewal of the Vertex Pharmaceuticals Incorporated (\"Vertex\") lease for 1.1 million square feet of office and laboratory space at 50 Northern Avenue and 11 Fan Pier Boulevard in Boston, Massachusetts. Vertex’s existing lease, which expires in December 2028, was extended for approximately 15 years, through June 2044.\nAdam Portnoy, President and Chief Executive Officer of RMR, made the following statement:\n\"The Vertex lease extension exemplifies the successful execution of The RMR Group’s strategy to create value for our clients. We have cultivated a strong relationship with Vertex, which has resulted in their recommitting to their flagship location in Boston’s Seaport District for a 15-year lease extension that enhances the value of our clients’ assets. We look forward to continuing our longstanding relationship with Vertex and providing them with a supportive environment for Vertex to pursue transformative medicines for people with serious diseases.\"\nThe properties leased to Vertex are owned by a joint venture, for which RMR provides asset and property management services, and in which Diversified Healthcare Trust (Nasdaq: DHC), an RMR client, owns a 10% equity interest.\nAbout The RMR Group\nThe RMR Group is a leading U.S. alternative asset management company, unique for its focus on commercial real estate (CRE) and related businesses. RMR’s vertical integration is supported by over 1,100 real estate professionals in more than 35 offices nationwide who manage over $41 billion in assets under management and leverage more than 35 years of institutional experience in buying, selling, financing and operating CRE. RMR benefits from a scalable platform, a deep and experienced management team and a diversity of direct real estate strategies across its clients. RMR is headquartered in Newton, MA and was founded in 1986. For more information, please visit rmrgroup.com.\nAbout Diversified Healthcare Trust\nDHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of March 31, 2024, DHC’s approximately $7.2 billion portfolio included 371 properties in 36 states and Washington, D.C., occupied by approximately 500 tenants, and totaling approximately 8.5 million square feet of life science and medical office properties and more than 27,000 senior living units. DHC is headquartered in Newton, MA. For more information, visit dhcreit.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20240818899101/en/\nContacts\nKevin BarrySenior Director, Investor Relations(617) 769-8230","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2460338310"}